Bert Slade, MD, Joins Tissue Tech as VP, Clinical Development
Former Chief Scientific and Medical Officer Advanced Wound Care, Smith & Nephew
Life Science Partner recruited Bert Slade, MD, to serve as the Vice President, Clinical Development for TissueTech. Slade has built his career in leading clinical trials, medical affairs, and regulatory approvals for medical device and pharmaceutical companies worldwide. He joins TissueTech while also providing clinical support for Chisholm Clinical Research Services where he has set up his own vehicle to conduct clinical trials using the European platform as an inroad to EU product approvals.
During his tenure at Smith and Nephew, Slade was challenged as the first CMO for the Advanced Wound Management Division to restructure the three-strategic business unit R&D Departments and two clinical groups into a single international R&D organization with the addition of post-marketing surveillance.
“With his extensive experience in FDA submissions of BLAs and NDAs including a clinical background in wound healing and regenerative medicine, Slade will serve as a critical asset for TissueTech’s clinical trial designs and submissions,” states Tom Callaway, President and Founding Partner of Life Science Partner.
Slade earned his Bachelor of Arts Degree in Biology from Hamilton College. He earned his MD from the Upstate Medical Center at the University of New York.